Public Health
Pain relief from coronavirus may be helping it spread
Rather than feeling sick, some people may be getting pain relief from coronavirus — a discovery that could impact both the pandemic and the opioid epidemic.
A new molecule may take the edge off vaccines — and make them perform better
Adjuvants create a better vaccine immune response, but they also cause inflammation. A peptide may help curb their side effects while improving protection.
Coronavirus nasal spray vaccine nears human trials
A nasal spray vaccine for COVID-19 that contains a live coronavirus genetically engineered to replicate more slowly is nearing human trials.
Johnson & Johnson’s COVID-19 vaccine reaches final trial stage
Johnson & Johnson’s COVID-19 vaccine isn’t the first to reach the final human trial stage, but it may have several advantages over its predecessors.
Studying pig sh*t to prevent the next pandemic
A pilot program in North Carolina offers one solution to scanning for a potential pig virus in our farm system - slurry testing.
This edible sensor can alert you of food contamination
A microneedle patch made of silk changes color if it senses food contamination or spoilage, making it easier to know when food’s gone bad.
What we know about COVID-19 reinfection so far
Researchers have reported four cases of COVID-19 reinfection, with patients recovering from the coronavirus and later testing positive for another strain.
A patient’s sex may affect their COVID-19 immune response
Key differences in the COVID-19 immune response of men and women could potentially explain a disparity in patient outcomes.
Influenza virus may be transmitted by particles in the air
Airborne particles like dust and dander not caused by breathing — “aerosolized fomites” — may be a route of influenza virus transmission.
$5 COVID-19 test could be a game changer in the US
Abbott Laboratories’ $5 COVID-19 test has secured an FDA authorization, meaning the U.S. now has access to a fast, accurate antigen test.